1
|
Rodier S, Henning J, Kukreja J, Mohammedi T, Shah P, Damani T. Robotic Primary and Revisional Hiatal Hernia Repair is Safe and Associated with Favorable Perioperative Outcomes: A Single Institution Experience. J Laparoendosc Adv Surg Tech A 2023; 33:932-936. [PMID: 37417969 DOI: 10.1089/lap.2023.0218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/08/2023] Open
Abstract
Background: Robotic hiatal hernia (HH) repair has been demonstrated to be feasible and safe. Recent conflicting reports have emerged on the higher incidence of perioperative complications with robotic HH repair when compared with laparoscopic repair. Materials and Methods: A retrospective review of a prospective database at an academic medical center for all robotic HH repairs performed by a high-volume foregut surgeon from 2018 to 2021 was performed. Outcome measures included operative time, estimated blood loss (EBL), length of stay (LOS), conversion rate, need for esophageal lengthening procedure, intra- and perioperative complications, and 30-day in-hospital mortality. Results: One hundred four patients were included in the analysis. Fifteen percent of patients had a type I HH, 2% had a type II, 73% had a type III, and 10% had a type IV HH. Eighty-four percent of cases were primary and 16% were revisional. Fifty-four percent of patients had mesh placed and 4.4% had an esophageal lengthening procedure. Mean EBL was 15 mL and mean operative time was 151 minutes. Median LOS was 2 days (interquartile range 1-2 days). There were zero conversions. Intraoperative complication rate was 1% and 30-day complication rate was 4%. The 30-day in-hospital mortality was zero. Conclusion: In this retrospective analysis of 114 consecutive robotic HH repairs performed, with 83% type III or IV HHs and 16% revisional hiatal cases, our results demonstrate favorable perioperative outcomes, with lower EBL, shorter LOS, lower complication rate, zero conversions, and comparable operative times compared with historical laparoscopic data.
Collapse
Affiliation(s)
- Simon Rodier
- Department of Surgery, NYU Langone Health, New York, New York, USA
| | - Justin Henning
- Department of Surgery, NYU Langone Health, New York, New York, USA
| | - Janvi Kukreja
- Division of the Biological Sciences, University of Chicago, Chicago, Illinois, USA
| | - Taher Mohammedi
- Department of Surgery, NYU Langone Health, New York, New York, USA
| | - Paresh Shah
- Department of Surgery, NYU Langone Health, New York, New York, USA
| | - Tanuja Damani
- Department of Surgery, NYU Langone Health, New York, New York, USA
| |
Collapse
|
2
|
Huddleston S, Hertz M, Loor G, Garcha P, Hartwig M, Snyder L, Siddique A, Strah H, Kukreja J, Song T, Jablonski R, Smith M, Walia R, Arjuna A, Lozonschi L, Patel K, Katlaps G, Nemeh H, Suarez E, Huang H, Langer N, Madsen J, Lee A, Dhillon G, MacArthur J, Keshavamurthy S, Nandavaram S, Daneshmand M, Neujahr D, Bush E, Joyce D, Ardehali A, Budev M, McCurry K. Impact of National OCS Lung Procurement & Management Program on Post-Transplant Survival - Real World Data from the Thoracic Organ Perfusion (TOP) Post-Approval Registry. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.1012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
3
|
Aguilar O, Qualls A, Gonzalez-Hinojosa M, Singer J, Raymond W, Hays S, Golden J, Kukreja J, Diamond J, Christie J, Lanier L, Greenland J, Calabrese D. A Single Nucleotide Polymorphism in Donor MICB Protects from NKG2D-Mediated Primary Graft Dysfunction and Death. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
4
|
Loor G, Garcha P, Huddleston S, Hertz M, Hartwig M, Snyder L, Siddique A, Strah H, Kukreja J, Song T, Jablonski R, Smith M, Walia R, Arjuna A, Lozonschi L, Patel K, Katlaps G, Nemeh H, Suarez E, Huang H, Langer N, Madsen J, Lee A, Dhillon G, MacArthur J, Keshavamurthy S, Nandavaram S, Daneshmand M, Neujahr D, Bush E, Joyce D, Ardehali A, Budev M, McCurry K. Impact of OCS Lung Warm Perfusion Times on Post-Transplant Survival - "Real-World" Experience from Thoracic Organ Perfusion (TOP) Registry. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.1014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
5
|
Bromberger B, McLafferty F, Smith J, Elicker B, Jones K, Mulvey C, Urisman A, Venado A, Hays S, Kukreja J, Trinh B. Bilateral Lung Transplant with Recognition of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) of rhe Donor Lungs in the Immediate Postoperative Period. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.870] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
6
|
Loor G, Garcha P, Huddleston S, Hertz M, Hartwig M, Snyder L, Siddique A, Strah H, Kukreja J, Song T, Jablonski R, Smith M, Walia R, Arjuna A, Lozonschi L, Patel K, Katlaps G, Nemeh H, Suarez E, Huang H, Langer N, Madsen J, Lee A, Dhillon G, MacArthur J, Keshavamurthy S, Nandavaram S, Daneshmand M, Neujahr D, Bush E, Joyce D, Ardehali A, Budev M, McCurry K. First Report of the Organ Care System (OCS) Thoracic Organ Perfusion (TOP) Post-Approval Registry. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
7
|
Ware L, Koyama T, Nguyen J, Swain S, Kukreja J, Dhillon G, Weigt S, Singer J, Matthay M. Randomized Trial of Protective Lung Ventilation in Organ Donors. J Heart Lung Transplant 2022. [DOI: 10.1016/j.healun.2022.01.1619] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
8
|
Maheshwari J, Perez A, Kolaitis N, Calabrese D, Estrada AV, Golden J, Shah R, Leard L, Kleinhenz M, Jones K, Urisman A, Kukreja J, Trinh B, Gesthalter Y, Singer J, Hays S. Immunosuppression-Induced Pulmonary Alveolar Proteinosis Following Bilateral Lung Transplantation. J Heart Lung Transplant 2022. [DOI: 10.1016/j.healun.2022.01.737] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
9
|
Calabrese D, Singer J, Hays S, Leard L, Golden J, Kolaitis N, Kleinhenz M, Shah R, Venado A, Kukreja J, Belperio J, Weigt S, Greenland J, Looney M. Bronchoalveolar Lavage MICB is Associated with Severe Primary Graft Dysfunction, Prolonged Mechanical Ventilation, and Low Post-Transplant FEV1 in Lung Transplant Recipients. J Heart Lung Transplant 2022. [DOI: 10.1016/j.healun.2022.01.174] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
10
|
Loor G, Warnecke G, Villavicencio M, Smith M, Kukreja J, Ardehali A, Hartwig M, Daneshmand M, Hertz M, Huddleston S, Haverich A, Madsen J, Neyrinck A, Van Raemdonck D. Long-Term Results of the OCS Lung Expand International Trial Using Organ Care System Lung Perfusion System (OCS) in Extended-Criteria Donor (ECD) and Donation After Circulatory Death (DCD) Donor Lungs. J Heart Lung Transplant 2022. [DOI: 10.1016/j.healun.2022.01.097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
11
|
Seijo L, Smith P, Greenland J, Gao Y, Kolaitis N, Venado A, Hays S, Thakur N, Kukreja J, Leard L, Golden J, Shah R, Kleinhenz M, Perez A, Trinh B, Betancourt L, Medikonda N, Calabrese D, Blanc P, Katz P, Singer J. Worsening in the Lung Transplant-Valued Life Activities Scale is Associated with Mortality in Lung Transplant Recipients. J Heart Lung Transplant 2022. [DOI: 10.1016/j.healun.2022.01.1344] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
12
|
Nguyen A, Trinh B, Deuse T, Singer J, Hays S, Venado A, Leard L, Shah R, Kleinhenz M, Kolaitis N, Calabrese D, Greenland J, Golden J, Brzezinski M, Kukreja J. Short-Term Outcomes of Lung Transplantation for COVID-19 ARDS: A Single Center Experience. J Heart Lung Transplant 2022. [PMCID: PMC8988588 DOI: 10.1016/j.healun.2022.01.1217] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Purpose The outcomes of lung transplant (LTx) for COVID-19 related lung disease are continuing to be examined. This study describes our experience in the first 7 cases. Methods This study included all patients received double LTx (DLTx) for COVID-19 acute respiratory distress syndrome (ARDS) between November 2020 and October 2021. Patient pre-LTx and perioperative characteristics as well as post-LTx outcomes are presented. Results Seven patients underwent DLTx for COVID-19 ARDS. All required mechanical ventilation (MV) pre-LTx. Six patients were male (85%), 5 Hispanic (71%), with a median age of 48 (IQR 40-53) and median body mass index of 23.6 (IQR 21.7-25.6). Six patients (85%) were on veno-venous extracorporeal membrane oxygenation (VV-ECMO) pre-LTx (one conversion from VV to veno-arterial (VA)). Median duration of MV and ECMO pre-LTx was 140 days (IQR 82-165) and 71.5 days (IQR 58-149), respectively. Two patients developed acute kidney injury pre-LTx requiring continuous renal replacement therapy (CRRT). Median time from listing to transplant was 17 days (IQR 10-24). ECMO was discontinued in all but 1 patient post-LTx. Median length of stay in the hospital post-LTx was 30 days (IQR 15-57). All were discharged from the hospital (43% to rehabilitation facility). Two patients on pre-LTx CRRT remained hemodialysis dependent and had multi-drug resistant (MDR) bacterial infections post-LTx. One readmission occurred for presumed rejection, aspiration and infection with MDR Klebsiella now requiring oxygen. All surgical pathology showed diffuse interstitial fibrosis consistent with the fibrotic sequelae of alveolar damage due to COVID-19. At 3-month follow-up, 6 patients (85%) did not need supplemental oxygen and had good pulmonary function. Conclusion Lung transplantation for COVID-ARDS is feasible. However, pre-transplant multi-system involvement may be associated with a protracted post-LTx stay and MDR infection. Further studies are needed to assess the long-term outcomes in this cohort.
Collapse
|
13
|
Singer J, Diamond J, Anderson M, Benvenuto L, Arcasoy S, Lederer D, Gao Y, Calabrese D, Hays S, Kukreja J, Venado A, Kolaitis N, Leard L, Shah R, Trinh B, Perez A, Golden J, Kleinhenz M, Betancourt L, Oyster M, Brown M, Kalman L, Zeleski D, Adler J, Medikonda N, Tevald M, Balar P, Patel S, Wang P, Greenland J, Christie J, Katz P. Preliminary Development of the Lung Transplant Frailty Index. J Heart Lung Transplant 2022. [DOI: 10.1016/j.healun.2022.01.110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
14
|
Singer J, Diamond J, Anderson M, Benvenuto L, Arcasoy S, Lederer D, Delucchi K, Gao Y, Wang P, Calfee C, Calabrese D, Hays S, Kukreja J, Venado A, Kolaitis N, Leard L, Shah R, Trinh B, Perez A, Kleinhenz M, Golden J, Betancourt L, Oyster M, Brown M, Zeleski D, Adler J, Medikonda N, Tevald M, Kalman L, Balar P, Patel S, Greenland J, Christie J. Molecular Phenotypes of Frailty in Lung Transplant Candidates. J Heart Lung Transplant 2022. [DOI: 10.1016/j.healun.2022.01.111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
15
|
Kolaitis N, Chen H, Calabrese D, Kumar K, Obata J, Bach C, Golden J, Simon M, Kukreja J, Hays S, Leard L, Singer J, De Marco T. The Lung Allocation Score Remains Inequitable for Patients with PAH, Even After the 2015 Revision. J Heart Lung Transplant 2022. [DOI: 10.1016/j.healun.2022.01.339] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
16
|
Santos J, Hays S, Golden J, Calabrese D, Kolaitis N, Kleinhenz M, Rupal S, Venado A, Leard L, Kukreja J, Singer J, Greenland J. Decreased Lymphocytic Bronchitis Severity in the Era of Azithromycin Prophylaxis. J Heart Lung Transplant 2022. [DOI: 10.1016/j.healun.2022.01.769] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
17
|
Venado A, Singer J, Leard L, Shah R, Kleinhenz M, Golden J, Perez A, Kolaitis N, Calabrese D, Maheshwari J, Trinh B, Kukreja J, Hays S. Measuring Quality in Lung Transplant Care: The QUILT Initiative. J Heart Lung Transplant 2021. [DOI: 10.1016/j.healun.2021.01.475] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
18
|
Teraoka J, Nguyen K, Hart D, Peace S, Leard L, Iyer G, Gordon D, Zuckerman B, Pascual J, Ponzo J, Perez A, Budanova N, Gesthalter Y, Trinh B, Kukreja J, Hays S, Venado A. Decreasing 30-day Readmissions for Pleural Effusions after Lung Transplant. J Heart Lung Transplant 2021. [DOI: 10.1016/j.healun.2021.01.1075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
19
|
Perez A, Singer J, Calabrese D, Venado A, Greenland J, Leard L, Shah R, Kolaitis N, Golden J, Kleinhenz M, Kukreja J, Trinh B, Hays S. Risk Factors and Rates of Fungal Infection in Lung Transplant Recipients Who Receive Posaconazole and Inhaled Amphotericin Combination Prophylaxis Therapy. J Heart Lung Transplant 2021. [DOI: 10.1016/j.healun.2021.01.966] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
20
|
Diamond J, Courtwright A, Balar P, Oyster M, Zaleski D, Adler J, Hays S, Sutter N, Garvey C, Kukreja J, Gao Y, Bruun A, Smith P, Singer J. mHealth to Improve Emergent Frailty after Lung Transplantation. J Heart Lung Transplant 2021. [DOI: 10.1016/j.healun.2021.01.1914] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
21
|
Maheshwari J, Greenland J, Gao Y, Hays S, Katz P, Blanc P, Kolaitis N, Golden J, Kukreja J, Shah R, Leard L, Trinh B, Covinsky K, Calabrese D, Venado A, Huang C, Kleinhenz M, Sutter N, Tietje-Ulrich G, Singer J. Frailty is Associated with Subsequent Development of Chronic Lung Allograft Dysfunction Following Lung Transplantation. J Heart Lung Transplant 2021. [DOI: 10.1016/j.healun.2021.01.856] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
22
|
Odisho A, Singer J, Perez A, Leard L, Shah R, Golden J, Kleinhenz M, Kolaitis N, Maheshwari J, Liu A, Trinh B, Kukreja J, Greenland J, Calabrese D, Hays S. Implementation of a Chatbot Mobile Health Intervention with Home Spirometry to Monitor Lung Transplant Recipients Remotely. J Heart Lung Transplant 2021. [DOI: 10.1016/j.healun.2021.01.446] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
23
|
Tsou S, Chen J, Feng C, Trinh B, Deuse T, Hays S, Golden J, Venado Estrada A, Singer J, Brzezinski M, Kukreja J. Delayed Chest Closure Following Bilateral Lung Transplantation: Risk Factors and Outcomes. J Heart Lung Transplant 2021. [DOI: 10.1016/j.healun.2021.01.485] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
24
|
Lazo J, Viduya J, Dewey K, Florez R, Singer J, Golden J, Hays S, Kukreja J, Greenland J, Calabrese D. Genotyping Predicts Osteoporosis Risk after Lung Transplantation. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.791] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
25
|
Gordon D, Hays S, Singer J, Perez A, Venado A, Iyer G, Zuckerman B, Daulton C, Pascual J, Dewey K, Florez R, Shah R, Kolaitis N, Leard L, Kleinhenz M, Golden J, Trinh B, Deuse T, Kukreja J. Reducing Length of Stay after Lung Transplant through Implementation of Multi-Disciplinary Care Coordination Rounds. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.829] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
26
|
Maheshwari J, Kolaitis N, Anderson M, Benvenuto L, Gao Y, Katz P, Wolters P, Golden J, Kukreja J, Hays S, Greenland J, Shah R, Leard L, Trinh B, Oyster M, Covinsky K, Calabrese D, Venado A, Patel P, Huang C, Glidden D, Kleinhenz M, Sutter N, Tietje-Ulrich G, Brown M, Arcasoy S, Christie J, Diamond J, Singer J. Sarcopenia is Associated with Frailty in Lung Transplant Candidates. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.514] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
27
|
DesJardin J, Svetlichnaya Y, Kolaitis N, Singer J, Hayes S, Kukreja J, De Marco T. Right Ventricular Outflow Tract Doppler Envelope Notching Predicts Pulmonary Hypertension and Outcomes in Lung Transplant Candidates. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.702] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
28
|
Cantu E, Bermudez C, Cevasco M, Suzuki Y, Buckley T, Galati V, Majeti N, Benvenuto L, Anderson M, Wille K, Weinacker A, Dhillon G, Orens J, Shah P, Lama V, McDyer J, Snyder L, Palmer S, Hartwig M, Hage C, Singer J, Calfee C, Kukreja J, Greenland J, Ware L, Hsu J, Gallop R, Diamond J, Christie J. Implications of ECMO Bridging and Salvage Strategies on Mortality and PGD. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.960] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
29
|
Perez A, Hays S, Gao Y, Soong A, Kleinhenz M, Leard L, Kukreja J, Venado A, Golden J, Shah R, Blanc P, Greenland J, Singer J. High Lung Allocation Scores Do Not Preclude Improvement in Health-Related Quality of Life after Lung Transplantation. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.557] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
30
|
Ceulemans L, Neyrinck A, Loor G, Warnecke G, Villavicencio M, Madsen J, Kukreja J, Hartwig M, Ardehali A, Huddleston S, Hertz M, Van Raemdonck D. Long (>6h) versus Short (<6h) Clinical Normothermic Ex-Vivo Portable Lung Preservation: Post-Hoc Analysis of OCS Lung EXPAND Trial. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.807] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
31
|
Ceulemans L, Neyrinck A, Loor G, Warnecke G, Villavicencio M, Madsen J, Kukreja J, Hartwig M, Ardehali A, Huddleston S, Hertz M, Van Raemdonck D. Lung Transplantation from Donation after Circulatory Death Donors Following Portable Ex-Vivo Lung Perfusion: Post-Hoc Analysis of OCS Lung EXPAND Trial. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.806] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
32
|
Kolaitis N, Soong A, Gao Y, Shah R, Venado A, Hays S, Kukreja J, Golden J, Leard L, Greenland J, Kleinhenz M, Katz P, Blanc P, Singer J. Frailty is Associated with Greater Impairments in Health-Related Quality of Life after Lung Transplantation Than Before. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.556] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
33
|
Wang P, Pelonero A, Looney T, Topacio-Hall D, Chang J, Kukreja J, Hays S, Golden J, Singer J, Lowman G, Greenland J. Preservation of the Donor-Reactive T Cell Repertoire Following Extracorporeal Photopheresis. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.1047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
34
|
Ardehali A, Van Raemdonck D, Kukreja J, Smith M, Loor G, Rea F, Massard G, De Robertis F, Nagendran J, Moradiellos J, Dhital K, Knosalla C, Bermudez C, Tsui S, Madsen J, Wang I, McCurry K, Deuse T, Thomas P, Tudorache I, Wiegmann B, Schiavon M, Calabrese F, Santelmo N, Olland A, Falcoz P, Varela A, Hertz M, Simon A, Resichenspurner H, Haverich A, Warnecke G. Negative Impact of Primary Graft Dysfunction Grade 3 within the Initial 72 Hours on Short and Long Term Clinical Outcomes in Standard Criteria Double Lung Transplants: Prospective Evidence from the OCS Lung INSPIRE International Trial Results. J Heart Lung Transplant 2018. [DOI: 10.1016/j.healun.2018.01.1195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
35
|
Venado A, Soong A, Shrestha P, Greenland J, Shah R, Hays S, Leard L, Golden J, Kukreja J, Katz P, McCulloch C, Singer J. The Clinical Trajectory of Frailty in Adults Undergoing Lung Transplantation. J Heart Lung Transplant 2018. [DOI: 10.1016/j.healun.2018.01.448] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
36
|
Loor G, Warnecke G, Villavicencio M, Smith M, Kukreja J, Ardehali A, Hartwig M, Daneshmand M, Hertz M, Haverich A, Madsen J, Van Raemdonck D. Results of the OCS Lung EXPAND International Trial Using Portable Normothermic OCS Lung Perfusion System (OCS) to Recruit and Evaluate Extended Criteria Donor (ECD) Lungs. J Heart Lung Transplant 2018. [DOI: 10.1016/j.healun.2018.01.356] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
37
|
Singer JP, Katz PP, Soong A, Shrestha P, Huang D, Ho J, Mindo M, Greenland JR, Hays SR, Golden J, Kukreja J, Kleinhenz ME, Shah RJ, Blanc PD. Effect of Lung Transplantation on Health-Related Quality of Life in the Era of the Lung Allocation Score: A U.S. Prospective Cohort Study. Am J Transplant 2017; 17:1334-1345. [PMID: 27743488 PMCID: PMC6085872 DOI: 10.1111/ajt.14081] [Citation(s) in RCA: 63] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2016] [Revised: 09/13/2016] [Accepted: 10/04/2016] [Indexed: 01/25/2023]
Abstract
Under the U.S. Lung Allocation Score (LAS) system, older and sicker patients are prioritized for lung transplantation (LT). The impact of these changes on health-related quality of life (HRQL) after transplant has not been determined. In a single-center prospective cohort study from 2010 to 2016, we assessed HRQL before and repeatedly after LT for up to 3 years using the SF12-Physical and Mental Health, the respiratory-specific Airway Questionnaire 20-Revised, and the Euroqol 5D/Visual Analog Scale utility measures by multivariate linear mixed models jointly modeled with death. We also tested changes in LT-Valued Life Activities disability, BMI, allograft function, and 6-min walk test exercise capacity as predictors of HRQL change. Among 211 initial participants (92% of those eligible), LT improved HRQL by all 5 measures (p < 0.05) and all but SF12-Mental Health improved by threefold or greater than the minimally clinically important difference. Compared to younger participants, those aged ≥65 improved less in SF12-Physical and Mental Health (p < 0.01). Improvements in disability accounted for much of the HRQL improvement. In the LAS era, LT affords meaningful and durable HRQL improvements, mediated by amelioration of disability. Identifying factors limiting HRQL improvement in selected subgroups, especially those aged ≥65, are needed to maximize the net benefits of LT.
Collapse
Affiliation(s)
- J P Singer
- Department of Medicine, University of California, San Francisco, CA
| | - P P Katz
- Department of Medicine, University of California, San Francisco, CA
| | - A Soong
- Department of Medicine, University of California, San Francisco, CA
| | - P Shrestha
- Department of Medicine, University of California, San Francisco, CA
| | - D Huang
- Department of Medicine, University of California, San Francisco, CA
| | - J Ho
- Department of Medicine, University of California, San Francisco, CA
| | - M Mindo
- Department of Medicine, University of California, San Francisco, CA
| | - J R Greenland
- Department of Medicine, University of California, San Francisco, CA
| | - S R Hays
- Department of Medicine, University of California, San Francisco, CA
| | - J Golden
- Department of Medicine, University of California, San Francisco, CA
| | - J Kukreja
- Department of Surgery, University of California, San Francisco, CA
| | - M E Kleinhenz
- Department of Medicine, University of California, San Francisco, CA
| | - R J Shah
- Department of Medicine, University of California, San Francisco, CA
| | - P D Blanc
- Department of Medicine, University of California, San Francisco, CA
| |
Collapse
|
38
|
Kolaitis N, Huang D, Soong A, Shrestha P, Golden J, Leard L, Shah R, Kleinhenz M, Greenland J, Katz P, Blanc P, Hays S, Kukreja J, Singer J. ECMO Prior to Lung Transplantation Does Not Impact Health-Related Quality of Life (HRQL) After Transplant. J Heart Lung Transplant 2017. [DOI: 10.1016/j.healun.2017.01.179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
39
|
Faust H, Golden J, Rajalingam R, Wang A, Green G, Hays S, Kukreja J, Singer J, Wolters P, Greenland J. Decreased Donor PBMC and Allograft Telomere Length Are Associated with Shorter CLAD-Free Survival. J Heart Lung Transplant 2017. [DOI: 10.1016/j.healun.2017.01.335] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
40
|
Calabrese D, Boettger R, Dewey K, Hui C, Torgerson D, Faust H, Rajalingam R, Hays S, Singer J, Shah R, Leard L, Kukreja J, Golden J, Greenland J. Impact of CYP3A5, CYP3A4, and ABCB1 Genotypes on Lung Transplant Recipient Early Clinical Outcomes. J Heart Lung Transplant 2017. [DOI: 10.1016/j.healun.2017.01.397] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
41
|
Hamilton BCS, Kukreja J, Ware LB, Matthay MA. Protein biomarkers associated with primary graft dysfunction following lung transplantation. Am J Physiol Lung Cell Mol Physiol 2017; 312:L531-L541. [PMID: 28130262 DOI: 10.1152/ajplung.00454.2016] [Citation(s) in RCA: 30] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2016] [Revised: 01/23/2017] [Accepted: 01/23/2017] [Indexed: 12/13/2022] Open
Abstract
Severe primary graft dysfunction affects 15-20% of lung transplant recipients and carries a high mortality risk. In addition to known donor, recipient, and perioperative clinical risk factors, numerous biologic factors are thought to contribute to primary graft dysfunction. Our current understanding of the pathogenesis of lung injury and primary graft dysfunction emphasizes multiple pathways leading to lung endothelial and epithelial injury. Protein biomarkers specific to these pathways can be measured in the plasma, bronchoalveolar lavage fluid, and lung tissue. Clarification of the pathophysiology and timing of primary graft dysfunction could illuminate predictors of dysfunction, allowing for better risk stratification, earlier identification of susceptible recipients, and development of targeted therapies. Here, we review much of what has been learned about the association of protein biomarkers with primary graft dysfunction and evaluate this association at different measurement time points.
Collapse
Affiliation(s)
- B C S Hamilton
- Department of Surgery, University of California San Francisco, San Francisco, California;
| | - J Kukreja
- Department of Surgery, University of California San Francisco, San Francisco, California
| | - L B Ware
- Department of Medicine and Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee
| | - M A Matthay
- Department of Medicine, Anesthesia, and the Cardiovascular Research Institute, University of California San Francisco, San Francisco, California; and
| |
Collapse
|
42
|
Tokman S, Hays SR, Leard LE, Bush EL, Kukreja J, Kleinhenz ME, Golden JA, Singer JP. Prolonged Barium-Impaction Ileus in Two Lung Transplant Recipients With Systemic Sclerosis: Case Report. Transplant Proc 2016; 47:2965-7. [PMID: 26707322 DOI: 10.1016/j.transproceed.2015.10.046] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2015] [Accepted: 10/20/2015] [Indexed: 11/15/2022]
Abstract
Lung transplantation can be a life-saving measure for people with end-stage lung disease from systemic sclerosis. However, outcomes of lung transplantation may be compromised by gastrointestinal manifestations of systemic sclerosis, which can involve any part of the gastrointestinal tract. Esophageal and gastric disease can be managed by enteral feeding with the use of a gastrojejunal feeding tube. In this report, we describe the clinical courses of 2 lung transplant recipients with systemic sclerosis who experienced severe and prolonged barium-impaction ileus after insertion of a percutaneous gastrojejunal feeding tube.
Collapse
Affiliation(s)
- S Tokman
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of California, San Francisco, California; Advanced Lung Disease and Lung Transplant Program, Norton Thoracic Institute, St Joseph's Hospital and Medical Center, Phoenix, Arizona.
| | - S R Hays
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of California, San Francisco, California
| | - L E Leard
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of California, San Francisco, California
| | - E L Bush
- Division of Cardiothoracic Surgery, Department of Surgery, University of California, San Francisco, California
| | - J Kukreja
- Division of Cardiothoracic Surgery, Department of Surgery, University of California, San Francisco, California
| | - M E Kleinhenz
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of California, San Francisco, California
| | - J A Golden
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of California, San Francisco, California
| | - J P Singer
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of California, San Francisco, California
| |
Collapse
|
43
|
Hamilton B, Dincheva G, Abbott J, Zhuo H, Golden J, Hays S, Brzezinski M, Singer J, Matthay M, Kukreja J. Elevated Plasma PAI-1 Levels in the Donor Are Associated with the Development of Primary Graft Dysfunction in Lung Transplant Recipients. J Heart Lung Transplant 2016. [DOI: 10.1016/j.healun.2016.01.901] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
44
|
Cowan B, Singer J, Shah R, Leard L, Kukreja J, Chin-Hong P, Watkins K, Boettger R, Golden J, Hays S. Fungal Colonization and Infection in Lung Transplant Recipients Receiving Posaconazole Prophylaxis. J Heart Lung Transplant 2016. [DOI: 10.1016/j.healun.2016.01.879] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
45
|
Venado A, Huang D, Greenland J, Hays S, Golden J, Shah R, Kukreja J, Singer J, Leard L. Lung Transplantation for Systemic Sclerosis: Long-Term Survival, Freedom from BOS and Readmission Rates. J Heart Lung Transplant 2016. [DOI: 10.1016/j.healun.2016.01.866] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
46
|
Warnecke G, Van Raemdonck D, Kukreja J, Smith M, Loor G, Rea F, Massard G, De Robertis F, Nagendran J, Moradiellos J, Dhital K, Knosalla C, Bermudez C, Tsui S, Madsen J, Wang I, McCurry K, Deuse T, Thomas P, Sommer W, Weigmann B, Khun C, Tudorache I, Avsar M, Schiavon M, Santelmo N, Olland A, Falcoz P, Varela A, Hertz M, Simon A, Resichenspurner H, Haverich A, Ardehali A. Mid and Long-Term Clinical Results of OCS Lung INSPIRE International Trial. J Heart Lung Transplant 2016. [DOI: 10.1016/j.healun.2016.01.042] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
47
|
Kukreja J, Kopchaliiska D, Dincheva G, Bush E, Leard L, Brzezinski M, Hays S, Singer J, Rajalingam R. IVIG Infusions Deplete Donor-Specific HLA Antibodies in Lung Transplant Recipients. J Heart Lung Transplant 2016. [DOI: 10.1016/j.healun.2016.01.671] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
48
|
Mansh M, Binstock M, Williams K, Hafeez F, Kim J, Glidden D, Boettger R, Hays S, Kukreja J, Golden J, Asgari M, Chin-Hong P, Singer J, Arron S. Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients. Am J Transplant 2016; 16:262-70. [PMID: 26372838 PMCID: PMC4718897 DOI: 10.1111/ajt.13431] [Citation(s) in RCA: 51] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2015] [Revised: 05/27/2015] [Accepted: 06/21/2015] [Indexed: 01/25/2023]
Abstract
Voriconazole is a triazole antifungal used to prevent and treat invasive fungal infections after lung transplantation, but it has been associated with an increased risk of developing cutaneous squamous cell carcinoma (SCC). Despite widespread use, there are no clear guidelines for optimal prophylactic regimens that balance the competing risks and benefits. We conducted a retrospective cohort study of all lung transplant recipients at the University of California, San Francisco, who were transplanted between October 1991 and December 2012 (n = 455) to investigate whether voriconazole exposure affected development of SCC, Aspergillus colonization, invasive aspergillosis and all-cause mortality. Voriconazole exposure was associated with a 73% increased risk of developing SCC (hazard ratio [HR] 1.73; 95% confidence interval [CI]: 1.04-2.88; p = 0.03), with each additional 30-day exposure at the standard dose increasing the risk by 3.0% (HR 1.03; 95% CI: 1.02-1.04; p < 0.001). Voriconazole exposure reduced risk of Aspergillus colonization by 50% (HR 0.50; 95% CI: 0.34-0.72; p < 0.001), but we were underpowered to detect risk reduction for invasive aspergillosis. Voriconazole exposure significantly reduced all-cause mortality among subjects who developed Aspergillus colonization (HR 0.34; 95% CI: 0.13-0.91; p = 0.03) but had no significant impact on those without colonization. Physicians should consider patient-specific factors that modify the potential risks and benefits of voriconazole for the care of lung transplant recipients.
Collapse
Affiliation(s)
- M. Mansh
- Department of Dermatology, University of California, San Francisco, California,Stanford University School of Medicine, Stanford, California
| | - M. Binstock
- Department of Dermatology, University of California, San Francisco, California
| | - K. Williams
- Department of Dermatology, University of California, San Francisco, California
| | - F. Hafeez
- Department of Dermatology, University of California, San Francisco, California
| | - J. Kim
- Department of Dermatology, University of California, San Francisco, California
| | - D. Glidden
- Department of Epidemiology and Biostatistics, University of California, San Francisco, California
| | - R. Boettger
- Department of Clinical Pharmacy, University of California, San Francisco, California
| | - S. Hays
- Department of Medicine, University of California, San Francisco, California
| | - J. Kukreja
- Department of Surgery, University of California, San Francisco, California
| | - J. Golden
- Department of Medicine, University of California, San Francisco, California
| | - M.M. Asgari
- Division of Research, Kaiser Permanente Northern California, Oakland, California
| | - P. Chin-Hong
- Department of Medicine, University of California, San Francisco, California
| | - J.P. Singer
- Department of Medicine, University of California, San Francisco, California
| | - S. Arron
- Department of Dermatology, University of California, San Francisco, California
| |
Collapse
|
49
|
Svetlichnaya J, Selby V, Singer J, Klein L, Janmohamed M, Hays S, Kukreja J, De Marco T. Right Ventricular Outflow Tract Doppler Envelope Mid-Systolic Notching Predicts Pulmonary Vascular Disease in Patients With Advanced Lung Disease. J Heart Lung Transplant 2015. [DOI: 10.1016/j.healun.2015.01.974] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
50
|
Greenland J, Wong C, Ahuja R, Uchida C, Golden J, Hays S, Leard L, Singer J, Kukreja J, Wolters P, Caughey G, Tang Q. Mild Acute Cellular Rejection Is Associated With Systemic Donor-Specific Regulatory and Conventional T Cell Responses. J Heart Lung Transplant 2015. [DOI: 10.1016/j.healun.2015.01.398] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|